Σημειώσεις επεισοδίου
Last week, Brazil's regulatory landscape for MedTech was redefined. ANVISA, the national health agency, unexpectedly rolled out a stringent new framework mandating advanced cybersecurity and data privacy compliance for all AI-driven medical devices. This sudden move disrupts market-entry plans and forces an immediate re-evaluation of regulatory strategies for companies targeting Latin America's largest market.
This episode dives deep into the practical consequences of this new regulation. We break down the specific documentation now required, from threat modeling to LGPD compliance, and…
Ιστότοπος: pureglobal.com

